CO4480038A1 - Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina - Google Patents

Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina

Info

Publication number
CO4480038A1
CO4480038A1 CO96029446A CO96029446A CO4480038A1 CO 4480038 A1 CO4480038 A1 CO 4480038A1 CO 96029446 A CO96029446 A CO 96029446A CO 96029446 A CO96029446 A CO 96029446A CO 4480038 A1 CO4480038 A1 CO 4480038A1
Authority
CO
Colombia
Prior art keywords
feline immunodeficiency
ivf
vaccine against
genetically altered
virus infections
Prior art date
Application number
CO96029446A
Other languages
English (en)
Inventor
Lloyd G Chavez
Terri Wasmoen
Huang Chengjin
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO4480038A1 publication Critical patent/CO4480038A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. UN PLASMIDO QUE CODIFICA EL GENOMA FIV DONDE EL GEN GAG DE DICHO GENOMA COMPRENDE UNA DELECCION DE NUCLEOTIDOS QUE CODIFICAN LA PROTEINA DE NU- CLEOTIDOS QUE CODIFICAN LA PROTEINA DE NUCLEOCAP- SIDA (p10) O UNA PORCION DE LA MISMA. UNA VACUNA QUE COMPRENDE VINONES DEL VIRUS DE IN- MUNODEFICIENCIA FELINA (FIV) QUE NO COMPRENDEN LA PROTEINA ENTERA DE NUCLEOCAPSIDA p10. 11. UN VINON DE FIV QUE NO COMPRENDE LA PROTEINA DE NUCLEOCAPSIDA ENTERA p10. 13. CELULAS HUESPEDES QUE SON TRANSFECTADAS CON UN PASMIDO QUE CODIFICA EL GENOMA FIV DONDE EL GEN Gaq DE DICHO GENOMA COMPRENDE UNA DELECCION DE NU- CLEOTIDOS QUE CODIFICA LA PROTEINA DE NUCLEOCAPSI- DE (p10) O UNA PORCION DE LA MISMA, DE MODO QUE DICHAS CELULAS PRODUCEN VINONES DE FIV QUE NO COM- PRENDEN PROTEINA DE NUCLEOCAPSIDA ENTERA p10. FIGURA 1
CO96029446A 1995-06-07 1996-06-06 Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina CO4480038A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/479,703 US6300118B1 (en) 1995-06-07 1995-06-07 Plasmids comprising a genetically altered feline immunodeficiency virus genome

Publications (1)

Publication Number Publication Date
CO4480038A1 true CO4480038A1 (es) 1997-07-09

Family

ID=23905072

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96029446A CO4480038A1 (es) 1995-06-07 1996-06-06 Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina

Country Status (10)

Country Link
US (1) US6300118B1 (es)
EP (1) EP0832265A1 (es)
JP (1) JPH11507515A (es)
AU (1) AU719034B2 (es)
BR (1) BR9608716A (es)
CA (1) CA2223969A1 (es)
CO (1) CO4480038A1 (es)
NZ (1) NZ310055A (es)
WO (1) WO1996040953A1 (es)
ZA (1) ZA964679B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2356200B (en) * 1997-12-22 2002-05-01 Oxford Biomedica Ltd Retroviral vectors
CN1322137C (zh) * 1997-12-22 2007-06-20 牛津生物医学（英国）有限公司 基于马传染性贫血病毒(eiav)的逆转录病毒载体
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
US6764676B1 (en) 1998-08-24 2004-07-20 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
EP1074625A3 (en) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
WO2006011919A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1697534B1 (en) 2003-12-01 2010-06-02 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
CA2550264C (en) * 2003-12-18 2011-06-28 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2556141A1 (en) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) * 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス（ｆｉｖ）のｅｎｖタンパク質のｖ３領域に由来するペプチドの使用を含むｆｉｖを検出するための方法および装置
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5256767A (en) 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
ATE208813T1 (de) 1988-02-16 2001-11-15 Greatbatch Gen Aid Ltd Modifizierte zellen mit resistenz gegen retroviralinfektionen
US5324664A (en) 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
US5674720A (en) * 1988-11-10 1997-10-07 United States Of America Design and construction of non-infectious human retroviral mutants deficient in genomic RNA
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
EP0860504A1 (en) 1989-05-08 1998-08-26 Idexx Laboratories, Inc. Polypeptides of feline T-cell lymphotropic lentivirus
US5252348A (en) 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
WO1993001278A1 (en) 1991-07-05 1993-01-21 The Regents Of The University Of California Feline lymphoid cell lines capable of producing fiv
US5413927A (en) 1991-09-03 1995-05-09 North Carolina State University Feline immunodeficiency virus isolate NCSU1Lb
AU2800392A (en) 1991-10-28 1993-06-07 Institut Pasteur Induction of protection against viral infection by synergy between viral proteins and viral peptides
ATE295895T1 (de) 1992-03-11 2005-06-15 Powderject Vaccines Inc Genetischer impfstoff gegen den immunschwäche virus
EP0576092B1 (en) 1992-06-26 2002-10-16 Akzo Nobel N.V. Recombinant Feline herpesvirus vaccine
GB9215233D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0662139A1 (en) 1992-09-21 1995-07-12 Chiron Corporation Recombinant retroviral vector against felv and/or fiv
WO1994020622A1 (en) 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus

Also Published As

Publication number Publication date
WO1996040953A1 (en) 1996-12-19
BR9608716A (pt) 1999-06-29
US6300118B1 (en) 2001-10-09
CA2223969A1 (en) 1996-12-19
AU719034B2 (en) 2000-05-04
EP0832265A1 (en) 1998-04-01
NZ310055A (en) 1999-06-29
AU6037296A (en) 1996-12-30
JPH11507515A (ja) 1999-07-06
ZA964679B (en) 1997-12-05

Similar Documents

Publication Publication Date Title
CO4480038A1 (es) Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
ATE298371T1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
BR9712138A (pt) Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
ES2045475T3 (es) Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus.
ES2194029T3 (es) Variantes del virus hiv-2.
CO4480039A1 (es) Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina
BR9814204A (pt) "obtenção de vacinas destinadas a prevenir os efeitos patogênicos associados a uma infecção retroviral"
HUP9902710A2 (hu) Rekombináns sertés-poxvírus
DK0599868T3 (da) Polyphenoloxidase-gener
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
EP0404625A3 (fr) Séquences oligonucléotidiques pour l'amplification du génome des rétrovirus du type HIV-2 et SIV, et leurs applications au diagnostic in-vitro des infections dûes à ces virus
ES2148164T3 (es) Cepa atenuada de vacuna del virus del sarampion, que contiene una secuencia nucleotidica especifica y procedimiento para su identificacion.
ES8800985A1 (es) Procedimiento de preparar proteinas.
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
ATE103980T1 (de) Das f-protein vom aids-virus enthaltender impfstoff.
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
ES2195994T3 (es) Virus recombinante de la enfermedad de marek, procedimiento de preparacion de este; y vacuna que lo contiene.
TR199802151T2 (xx) Geminivir�s genlerini sentezleyen transgenik bitkiler.
ES2037088T3 (es) Metodo para la mejora de la calidad de los animales.
DK631387D0 (da) Virusvektor
BR9508645A (pt) Vacina da peritonite infecciosa felina